Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Wet Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04126317
What this trial is testing

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Regeneron Pharmaceuticals 106
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Large-scale testing (Phase 3)Study completedNCT02243878
What this trial is testing

Stereotactic Radiotherapy for Wet AMD (STAR)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
King's College Hospital NHS Trust 411
Early research (Phase 1)Enrolling By InvitationNCT06737354
What this trial is testing

Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

Who this might be right for
nAMD
InnoVec Biotherapeutics Inc. 18
Large-scale testing (Phase 3)Study completedNCT04270747
What this trial is testing

Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Amgen 576
Large-scale testing (Phase 3)Looking for participantsNCT07695207
What this trial is testing

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
SANGMYUNG innovation 266
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT00964795
What this trial is testing

Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Regeneron Pharmaceuticals 323
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Post-approval studies (Phase 4)Study completedNCT02130024
What this trial is testing

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 281
Early research (Phase 1)Study completedNCT03814291
What this trial is testing

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 31
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Not applicableUnknownNCT00893724
What this trial is testing

Supplemental Adjuvants for Intracellular Nutrition and Treatment

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Mid-Atlantic Retina Consultations, Inc. 60
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Large-scale testing (Phase 3)Study completedNCT05989126
What this trial is testing

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)
Regeneron Pharmaceuticals 35
Post-approval studies (Phase 4)Study completedNCT01958918
What this trial is testing

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 712
Testing effectiveness (Phase 2)Study completedNCT03423823
What this trial is testing

Ziv-aflibercept Efficacy in Better Regulating AMD

Who this might be right for
Wet Macular DegenerationWet Age-related Macular Degeneration
Kapil Kapoor 62
Testing effectiveness (Phase 2)Study completedNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Large-scale testing (Phase 3)Study completedNCT03844074
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 61
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Next Page